Discover 1,423 paid clinical trials in Akron, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,423
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.
for
Relapsed AL Amyloidosis, Refractory AL Amyloidosis,
Location: Cleveland OH, Detroit MI, Toronto, New York NY,
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT07081646
Phase1, Phase2, Recruiting
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Cleveland OH, Marion OH, Pittsburgh PA, Scottdale PA,
Sponsor: AstraZeneca
Sex: All
Age: 40+
Code: NCT07082738
Phase2, Recruiting
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
for
Polymyositis, Dermatomyositis
Location: Cleveland OH, Pittsburgh PA, Ann Arbor MI, Baltimore MD,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06455449
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
for
Breast Cancer
Location: Cleveland OH, Detroit MI, Hamilton, Cincinnati OH,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06103864
Phase3, Recruiting
The Effect of Pollen Season on Subcutaneous Allergen Immunotherapy Reactions
Sponsor: University Hospitals Cleveland Medical Center
Sex: All
Age: 5+
Code: NCT01878929
Phase1, Phase2, Recruiting
New
Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
for
Non Hodgkin Lymphoma, B-cell Non Hodgkin Lymphoma,
Location: Cleveland OH
Sponsor: Paolo Caimi, MD
Sex: All
Age: 18+
Code: NCT07225439
Phase1, Recruiting
Prospective Surgical Study on the Pattern of Electrical Activity in High Grade Glioma as a Predictor of Progression
for
High Grade Glioma, Glioblastoma
Location: Cleveland OH
Sponsor: Case Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT05565118
Phase1, Recruiting
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML